Geode Capital Management, LLC Axsome Therapeutics, Inc. Put Options Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
408Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$354 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$313 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$181 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$105 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.6B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...